Huize Holding Limited/ US44473E1055 /
31/05/2024 19:59:49 | Var. +0.02 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
0.78USD | +2.50% | 8,110 Fatturato: 6,404.50 |
-Quantità in denaro: - | -Quantità in lettera: - | 0.80 | 0.78 |
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02/06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
02/06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
02/06
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
02/06
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
02/06
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...